Catalio, Tressa C.

HRN: 28-38-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/05/2026
02/06/2026
IV
4.5g
Now
T/cTyphoid S/p CS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: